BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6669479)

  • 1. Immunological role of vitamin A and its related substances in prevention of cancer.
    Tomita Y
    Nutr Cancer; 1983; 5(3-4):187-94. PubMed ID: 6669479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of tumor immunity against syngeneic tumors in mice by beta-carotene.
    Tomita Y; Himeno K; Nomoto K; Endo H; Hirohata T
    J Natl Cancer Inst; 1987 Apr; 78(4):679-81. PubMed ID: 3470543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activation and regulation of macrophages induced by inoculation of cryodestroyed tumor cells].
    Tsujino M
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):180-205. PubMed ID: 2135404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of astaxanthin and its mode of action.
    Jyonouchi H; Sun S; Iijima K; Gross MD
    Nutr Cancer; 2000; 36(1):59-65. PubMed ID: 10798217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of levamisole on methylcholanthrene-induced tumor. I. Its antitumor effect and immunological mechanism].
    Gomi K; Morimoto M; Nomoto K
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1262-8. PubMed ID: 7184454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatments with vitamin A and 5-fluorouracil and the growth of allotransplantable and syngeneic tumors in mice.
    Tomita Y; Himeno K; Nomoto K; Endo H; Hirohata T
    J Natl Cancer Inst; 1982 May; 68(5):823-7. PubMed ID: 6951091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of antitumor immunity by tumor cells treated with abrin.
    Shionoya H; Arai H; Koyanagi N; Ohtake S; Kobayashi H; Kodama T; Kato H; Tung TC; Lin JY
    Cancer Res; 1982 Jul; 42(7):2872-6. PubMed ID: 7083176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 10. The serologic response to Meth A sarcoma vaccines after cyclophosphamide treatment is additionally increased by various adjuvants.
    Livingston PO; Jones M; Deleo AB; Oettgen HF; Old LJ
    J Immunol; 1985 Aug; 135(2):1505-9. PubMed ID: 4008930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A).
    Khafagy M; Wanebo HJ; Alfieri A; Hahn EW
    AJR Am J Roentgenol; 1977 Jun; 128(6):1027-9. PubMed ID: 414534
    [No Abstract]   [Full Text] [Related]  

  • 12. Marked reduction of subcutaneous tumor growth by intraperitoneal administration of recombinant human interleukin 2 with a cell accumulator, proteose-peptone, in mice.
    Tanida S; Uchida H; Taniguchi K; Nomoto K
    Cancer Res; 1989 Jan; 49(2):284-8. PubMed ID: 2783379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
    Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
    Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment regimen and host T-cell-dependent therapeutic effect of interferon in mouse solid tumors.
    Kataoka T; Matsuura N; Oh-hashi F; Suhara Y
    Cancer Res; 1985 Aug; 45(8):3548-53. PubMed ID: 2410097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Corynebacterium granulosum on weight and histology of lymphoid organs, response to mitogens, skin allografts, and a syngeneic fibrosarcoma in mice.
    Milas L; Basic I; Kogelnik HD; Withers HR
    Cancer Res; 1975 Sep; 35(9):2365-74. PubMed ID: 807323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effect of recombinant human interferon alpha A/D on Meth-A sarcoma in mice.
    Yoshie O; Aso H; Nanjo M; Tamura K; Ebina T; Ishida N
    Jpn J Cancer Res; 1986 Apr; 77(4):413-8. PubMed ID: 3084432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antitumor effect of a novel antitumor compound, NC-190, in the double grafted tumor system].
    Ebina T; Shishido K; Murata K
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1345-50. PubMed ID: 2369138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of approaches for augmenting the serologic response to the individually specific methylcholanthrene-induced sarcoma-Meth A: pretreatment with cyclophosphamide is most effective.
    Livingston PO; DeLeo AB; Jones M; Oettgen HF
    J Immunol; 1983 Nov; 131(5):2601-5. PubMed ID: 6631013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
    J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation between tumour resistance and delayed-type hypersensitivity to tumour-associated antigens in the mouse.
    Henderson DC; Parker D; Turk JL
    Immunology; 1980 Jan; 39(1):1-9. PubMed ID: 7380461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.